Vendor Qualifications for Destruction Activities in Clinical Trials
Vendor Qualifications for Destruction Activities in Clinical Trials How to Qualify Vendors for Investigational Product Destruction in Clinical Trials In clinical trials, the destruction of unused, expired, or returned Investigational Products (IP) is a regulated and high-risk activity. Sponsors and Contract Research Organizations (CROs) must ensure that destruction vendors are appropriately qualified to handle pharmaceutical…
Read More “Vendor Qualifications for Destruction Activities in Clinical Trials” »